Onspira Therapeutics Overview

  • Founded
  • 2017
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Onspira Therapeutics General Information


Developer of therapies intended to treat rare, life threatening pulmonary diseases. The company's focus is on the development of life-changing medicines to bring hope to patients suffering from rare pulmonary diseases, providing patients with treatment for post-lung transplant bronchiolitis obliterans syndrome.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 640 Lee Road
  • Suite 117
  • Wayne, PA 19087
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Onspira Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 08-Jan-2020 00.000 Completed Generating Revenue
1. Early Stage VC 20-Jun-2019 00.000 00.000 Completed Stealth
To view Onspira Therapeutics’s complete valuation and funding history, request access »

Onspira Therapeutics Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioAdvance Venture Capital Minority 000 0000 000000 0
To view Onspira Therapeutics’s complete investors history, request access »